BOSTON SCIENTIFIC CORPORATION Estimated Litigation Liability, Current
BOSTON SCIENTIFIC CORPORATION (BSX) had Estimated Litigation Liability, Current of $152.00 million as of 2025-09-30, per its 10-Q filed 2025-11-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LitigationReserveCurrent · last filed 2025-11-03
- 2025-09-30: Estimated Litigation Liability, Current $152.00M.
- 2025-06-30: Estimated Litigation Liability, Current $131.00M.
- 2025-03-31: Estimated Litigation Liability, Current $137.00M.
- 2024-12-31: Estimated Litigation Liability, Current $177.00M.
| Period end | Estimated Litigation Liability, Current |
|---|---|
| 2025-09-30 | $152.00M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $131.00M 10-Q · filed 2025-08-01 |
| 2025-03-31 | $137.00M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $177.00M 10-Q · filed 2025-11-03 |
| 2024-09-30 | $126.00M 10-Q · filed 2024-11-01 |
| 2024-06-30 | $118.00M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $129.00M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $206.00M 10-K · filed 2025-02-18 |
| 2023-09-30 | $246.00M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $209.00M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $207.00M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $231.00M 10-K · filed 2024-02-20 |
| 2022-09-30 | $174.00M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $359.00M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $279.00M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $264.00M 10-K · filed 2023-02-23 |
| 2021-09-30 | $357.00M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $417.00M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $415.00M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $505.00M 10-K · filed 2022-02-23 |
| 2020-09-30 | $552.00M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $314.00M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $211.00M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $470.00M 10-K · filed 2021-02-23 |
| 2019-09-30 | $328.00M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $470.00M 10-Q · filed 2019-07-30 |
| 2019-03-31 | $527.00M 10-Q · filed 2019-04-29 |
| 2018-12-31 | $712.00M 10-K · filed 2020-02-25 |
| 2018-09-30 | $1.05B 10-Q · filed 2018-10-29 |
| 2018-06-30 | $1.04B 10-Q · filed 2018-07-31 |
| 2018-03-31 | $1.25B 10-Q · filed 2018-05-01 |
| 2017-12-31 | $1.18B 10-K · filed 2019-02-19 |
| 2017-09-30 | $1.35B 10-Q · filed 2017-11-02 |
| 2017-06-30 | $1.15B 10-Q · filed 2017-08-03 |
| 2017-03-31 | $1.24B 10-Q · filed 2017-05-03 |
| 2016-12-31 | $1.06B 10-K · filed 2018-02-20 |
| 2016-09-30 | $933.00M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $1.07B 10-Q · filed 2016-08-03 |
| 2016-03-31 | $788.00M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $773.00M 10-K · filed 2017-02-23 |
| 2015-09-30 | $383.00M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $283.00M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $515.00M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $694.00M 10-K · filed 2016-02-24 |
| 2014-09-30 | $75.00M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $81.00M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $98.00M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $84.00M 10-K · filed 2015-02-25 |
| 2013-09-30 | $450.00M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $405.00M 10-Q · filed 2013-08-07 |
| 2013-03-31 | $127.00M 10-Q · filed 2013-05-07 |
| 2012-12-31 | $100.00M 10-K · filed 2014-02-26 |
| 2012-09-30 | $94.00M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $98.00M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $137.00M 10-Q · filed 2012-05-03 |
| 2011-12-31 | $129.00M 8-K · filed 2013-05-29 |
| 2011-09-30 | $130.00M 10-Q · filed 2011-11-08 |
| 2011-06-30 | $133.00M 10-Q · filed 2011-08-05 |
| 2011-03-31 | $134.00M 10-Q · filed 2011-05-05 |
| 2010-12-31 | $441.00M 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |